Volume -10 | Issue -2
Volume -10 | Issue -2
Volume -10 | Issue -2
Volume -10 | Issue -2
Volume -10 | Issue -2
Background theory People with (T2DM) typically have a condition known as chronic kidney disease (CKD).As a result, one of the complications that led to morbidity, mortality, and patients staying in the hospital for an extended period of time. Fetuin-B is a new cytokine that is synthesized and released from the liver in various diseases as a marker for progression outcomes. In the past several years, (T2DM) and (CKD) have been linked (T2DM)